We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCS icon
1601
Marcus Corp
MCS
$766M
$1.47M ﹤0.01%
91,643
-20,667
-18% -$317K
NSTB.WS
1602
CALL
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$1.46M ﹤0.01%
145,996
-97,997
-40% -$5.05K
BN icon
1603
Brookfield
BN
$104B
$1.46M ﹤0.01%
67,277
-753,679
-92% -$17M
VDC icon
1604
Vanguard Consumer Staples ETF
VDC
$8.14B
$1.46M ﹤0.01%
+7,550
New +$1.43M
BMRN icon
1605
BioMarin Pharmaceuticals
BMRN
$12B
$1.46M ﹤0.01%
15,013
-585,259
-97% -$60.7M
CLINR
1606
CALL
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$1.46M ﹤0.01%
140,862
ING icon
1607
ING
ING
$95.1B
$1.45M ﹤0.01%
+122,534
New +$1.62M
LOB icon
1608
Live Oak Bancshares
LOB
$1.99B
$1.45M ﹤0.01%
59,672
-276,951
-82% -$8.69M
HBNC icon
1609
Horizon Bancorp
HBNC
$1.06B
$1.45M ﹤0.01%
130,662
+88,433
+209% +$1.27M
MGRC icon
1610
McGrath RentCorp
MGRC
$2.95B
$1.44M ﹤0.01%
+15,465
New +$1.53M
HNI icon
1611
HNI Corp
HNI
$3.17B
$1.44M ﹤0.01%
51,583
+2,265
+5% +$67.3K
ZH
1612
Zhihu
ZH
$281M
$1.43M ﹤0.01%
187,730
-148,658
-44% -$1.38M
ACHR.WS icon
1613
CALL
Archer Aviation Redeemable Warrants
ACHR.WS
$17M
$1.43M ﹤0.01%
500,000
-50,000
-9% -$22.2K
BFAM icon
1614
Bright Horizons
BFAM
$4.24B
$1.43M ﹤0.01%
18,548
-46,189
-71% -$3.55M
BZUN
1615
Baozun
BZUN
$168M
$1.42M ﹤0.01%
236,429
-76,936
-25% -$507K
SHAP.WS
1616
CALL
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$1.42M ﹤0.01%
135,147
CB icon
1617
Chubb
CB
$141B
$1.41M ﹤0.01%
+7,287
New +$1.53M
RMGCW
1618
CALL
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$1.41M ﹤0.01%
140,095
INTEW
1619
CALL
DELISTED
Integral Acquisition Corporation 1 Warrants
INTEW
$1.41M ﹤0.01%
137,552
VKTX icon
1620
Viking Therapeutics
VKTX
$3.93B
$1.41M ﹤0.01%
84,723
+14,388
+20% +$149K
SNX icon
1621
TD Synnex
SNX
$19.8B
$1.41M ﹤0.01%
+14,557
New +$1.45M
ZLSWW
1622
CALL
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$1.4M ﹤0.01%
137,552
SNA icon
1623
Snap-on
SNA
$21.7B
$1.4M ﹤0.01%
+5,661
New +$1.38M
SPYG icon
1624
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.4B
$1.4M ﹤0.01%
+25,208
New +$1.33M
WF icon
1625
Woori Financial
WF
$15.9B
$1.39M ﹤0.01%
53,055
-11,195
-17% -$321K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.